QT
IBB icon

Quantbot Technologies’s iShares Biotechnology ETF IBB Stock Holding History

Quantbot Technologies’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,631
Closed -$613K – 2063
2026
Q1 		$613K Sell
3,631
-3,369
-48% -$576K 0.03% 790
2025
Q4 		$1.18M Buy
7,000
+797
+13% +$129K 0.04% 632
2025
Q3 		$896K Sell
6,203
-4,057
-40% -$554K 0.02% 807
2025
Q2 		$1.3M Sell
10,260
-1,616
-14% -$198K 0.03% 680
2025
Q1 		$1.52M Buy
+11,876
New +$1.61M 0.05% 540
2024
Q4 		– Sell
-2,386
Closed -$347K – 1636
2024
Q3 		$347K Sell
2,386
-9,858
-81% -$1.43M 0.01% 917
2024
Q2 		$1.68M Buy
+12,244
New +$1.63M 0.08% 364
2024
Q1 		– Sell
-4,412
Closed -$599K – 1724
2023
Q4 		$599K Sell
4,412
-3,373
-43% -$412K 0.03% 663
2023
Q3 		$952K Buy
+7,785
New +$990K 0.06% 432
2023
Q2 		– Sell
-3,986
Closed -$515K – 1736
2023
Q1 		$515K Sell
3,986
-968
-20% -$127K 0.04% 602
2022
Q4 		$650K Sell
4,954
-5,873
-54% -$759K 0.05% 489
2022
Q3 		$1.27M Buy
10,827
+7,555
+231% +$938K 0.1% 324
2022
Q2 		$384K Buy
+3,272
New +$388K 0.04% 683
2021
Q4 		– Sell
-966
Closed -$156K – 1685
2021
Q3 		$156K Sell
966
-10,487
-92% -$1.76M 0.01% 869
2021
Q2 		$1.87M Sell
11,453
-5,547
-33% -$854K 0.15% 203
2021
Q1 		$2.56M Buy
+17,000
New +$2.7M 0.24% 110
2020
Q4 		– Sell
-14,738
Closed -$2M – 1455
2020
Q3 		$2M Buy
+14,738
New +$2M 0.23% 134
2020
Q1 		– Sell
-7,300
Closed -$879K – 1117
2019
Q4 		$879K Buy
7,300
+2,269
+45% +$253K 0.09% 272
2019
Q3 		$500K Buy
+5,031
New +$527K 0.05% 455

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Quantbot Technologies's IBB Position: Q2 2026 in Review

Quantbot Technologies sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 3,631 shares — an estimated $613K sold.

Quantbot Technologies first reported a position in IBB in Q3 2019 and held it in 19 quarters. The position peaked at $2.56M in Q1 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Quantbot Technologies reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
  • Quantbot Technologies sold 3,631 iShares Biotechnology ETF shares in Q2 2026, an estimated $613K.
  • Quantbot Technologies first reported a position in iShares Biotechnology ETF in Q3 2019 and held it in 19 quarters.
  • Quantbot Technologies's iShares Biotechnology ETF position peaked at $2.56M in Q1 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.